Use of unlicensed and off-label drugs in neonates in a Brazilian university hospital
Open Access
- 1 February 2018
- journal article
- research article
- Published by FapUNIFESP (SciELO) in Brazilian Journal of Pharmaceutical Sciences
- Vol. 53 (3)
Abstract
This study was designed to investigate the use of off-label and unlicensed drugs in a Neonatal Care Unit (NCU) and to compare the frequency of use of off-label drugs according to the drug regulatory agencies in Brazil (Agência Nacional de Vigilância Sanitária-ANVISA) and the United States Food and Drug Administration (FDA). A prospective observational study was carried out in the NCU. Prescriptions were classified as off-label and unlicensed using both ANVISA and FDA criteria. A total of 157 newborns and 1187 prescriptions were analyzed. The most prescribed drug was fentanyl (9.3%), followed by multivitamin (8.4%) and gentamicin (7.9%). According to ANVISA criteria, there were 665 (56.0%) off-label prescriptions and 86 (7.2%) unlicensed prescriptions and 95.5% of newborns received at least one drug off-label. By contrast, according to FDA criteria, there were 592 (49.9%) off-label prescriptions and 84 (7.1%) unlicensed prescriptions, and 72.0% of newborns received at least one drug off-label. The off-label use of drugs registered by ANVISA differed significantly from that of drugs registered by the FDA. There was a high frequency of off-label and unlicensed drug use in the investigated NCU, and there was an inverse relationship between off-label and unlicensed usage and the gestational age of the newborns.Keywords
This publication has 26 references indexed in Scilit:
- Paediatric drug use with focus on off‐label prescriptions at Swedish hospitals – a nationwide studyActa Paediatrica, 2012
- Off-label drug use in children should be rationalArchives of Disease in Childhood, 2011
- Unlicensed and off‐label drug use in a neonatal unit in FranceActa Paediatrica, 2010
- Association between licence status and medication errorsArchives of Disease in Childhood, 2010
- Off-label use of medicines in children: can available evidence avoid useless paediatric trials?European Journal of Clinical Pharmacology, 2008
- Off-label and unlicensed prescribing for newborns and children in different settings: a review of the literature and a consideration about drug safetyExpert Opinion on Drug Safety, 2006
- A literature review on off-label drug use in childrenEuropean Journal of Pediatrics, 2005
- Identificação de medicamentos "não apropriados para crianças" em prescrições de unidade de tratamento intensivo pediátricaJornal de Pediatria, 2003
- Adverse drug reactions to unlicensed and off‐label drugs on paediatric wards: a prospective studyActa Paediatrica, 1999
- Unlicensed and off label drug use in neonates CommentaryArchives of Disease in Childhood - Fetal and Neonatal Edition, 1999